About the Speaker
| Prof Tunku Kamarul Zaman Tunku Zainol Abidin
Professor, Department of Orthopaedic Surgery,
University of Malaya Medical Centre, Malaysia |
Professor Tunku Kamarul Zaman Tunku Zainol Abidin is presently the director of University of Malaya Medical Centre (UMMC), a premier 1500-bed university hospital in Malaysia staffed by over 5,000 personnel. He is by profession an orthopaedic surgeon with special interest in upper limb and microsurgery.
He was awarded a national scholarship to pursue his subspecialty training in the Royal Liverpool and Broadgreen Hospitals from 2006 till 2010. During that period, he also obtained a PhD degree from The University of Liverpool. Upon his return to Malaysia in 2010, he was appointed the head of the tissue engineering group, a division under The National Orthopaedic Centre for Research and Learning (NOCERAL). This research group comprises many researchers of which Prof Kamarul (as he is commonly known) supervises, including post-doctoral, doctoral and other post-graduate students as well as undergraduate students. He has had extensive teaching experience at all levels from undergraduate programmes to PhDs. This group is actively involved in basic science orthopaedic related research that ranges from biomechanics to cell biology. Prof Kamarul is however presently pursuing fundamental orthopaedic research involving cartilage, tendons and stem cell applications. He also heads the Masters of Regenerative Medicine programme in University of Malaya.
He has published over 150 peer-reviewed articles in many impact-factored journals and has been invited to present the research groups' discoveries at numerous international scientific meetings. Prof Kamarul is also heavily involved in the administrative duties of his institution. His previous administrative duties also included being the Deputy Dean of Research for Faculty of Medicine, Acting Dean for the Faculty of Medicine, Deputy Director (Clinical) for UMMC, Director for the Clinical Investigative Centre in UMMC (an internationally award-winning centre that conducts over 200 clinical trials a year) and, Head of Research in NOCERAL.
Speaker's Session:
